SCHEMBL7958672

SCHEMBL7958672

O=Cc1ccc(N2CCN(c3ccncc3)CC2)cc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.66
TRIM33 Q9UPN9 1/20 0.66
ALDH1A1 P00352 6/20 0.65
SMN1; SMN2 Q16637 4/20 0.63
KDM4E B2RXH2 3/20 0.63
CHKA P35790 1/20 0.55
ADRB2 P07550 1/20 0.50
NCF1 P14598 1/20 0.50
PLD1 Q13393 1/20 0.50
MAPT P10636 3/20 0.46
HTT P42858 1/20 0.46
AKR1C3 P42330 1/20 0.45
METAP1 P53582 1/20 0.45
MAPK1 P28482 1/20 0.44
CYP17A1 P05093 2/20 0.42
CYP21A2 P08686 2/20 0.42
CYP11B1 P15538 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2561698 0.88 TRIM24 (0.83) TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E
SCHEMBL3077544 0.88 TRIM24 (0.83) TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E
SCHEMBL23922755 0.84 POLB (0.63) TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E
SCHEMBL28699791 0.84 SMN1; SMN2 (0.69) TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E
SCHEMBL28704014 0.81 TRIM24 (0.56) TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E
SCHEMBL28112415 0.81 CHKA (0.80) SMN1; SMN2KDM4ECHKAADRB2NCF1
SCHEMBL7660354 0.80 MAPT (0.62) TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E
SCHEMBL1443539 0.80 TRIM24 (0.70) TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E
SCHEMBL253732 0.79 TRIM24 (1.00) TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E
SCHEMBL7180854 0.79 TRIM24 (0.91) TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563092-B 2-phenylimidazo [4,5-B ] pyridin-7-amine derivatives useful as inhibitors of the activity of the mammalian tyrosine kinase ROR1 坎塞拉有限公司 2021-09-14 CN disclosed
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed
EP-0880501-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997028128-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1997-08-07 WO disclosed